HomeMLTX • NASDAQ
add
MoonLake Immunotherapeutics
Previous close
$48.83
Day range
$46.73 - $49.81
Year range
$31.42 - $58.26
Market cap
3.01B USD
Avg Volume
569.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 47.48M | 139.58% |
Net income | -39.94M | -192.14% |
Net profit margin | — | — |
Earnings per share | -0.63 | -186.36% |
EBITDA | -47.11M | -141.67% |
Effective tax rate | -0.38% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 480.13M | -12.23% |
Total assets | 511.26M | -9.37% |
Total liabilities | 98.68M | 741.22% |
Total equity | 412.58M | — |
Shares outstanding | 63.47M | — |
Price to book | 7.61 | — |
Return on assets | -24.00% | — |
Return on capital | -25.14% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -39.94M | -192.14% |
Cash from operations | -38.14M | -155.15% |
Cash from investing | 56.25M | 295.27% |
Cash from financing | 73.12M | 43.44% |
Net change in cash | 91.14M | 1,153.30% |
Free cash flow | -25.47M | -68.33% |
About
Founded
2020
Headquarters
Website
Employees
100
